Literature DB >> 11266284

Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model.

S Ikenaga1, K Hamano, M Nishida, T Kobayashi, T S Li, S Kobayashi, M Matsuzaki, N Zempo, K Esato.   

Abstract

BACKGROUND: Bone marrow possesses endothelial progenitor cells that secrete several growth factors and can contribute to the formation of new capillaries. In the present study, we investigated the extent of angiogenesis induced by implantation of autologous bone marrow cells (BMCs) in a rat ischemic hindlimb model and studied whether the increased collateral vessels can improve deteriorated physical function.
MATERIALS AND METHODS: Ischemic hindlimb was created by ligation of the femoral artery and its branches in Dark Agouti (DA) rats. BMCs (1 x 10(7)) were injected percutaneously at six points into the gastrocnemius muscle. To assess angiogenesis, histologic evaluation and microangiography were performed at 2 weeks postligation. Severity of the ischemic insult was evaluated by measuring blood flow in the adductor and gastrocnemius muscles using nonradioactive colored microspheres and by determining the femoral arteriovenous oxygen difference (AVDO(2)) at 2 weeks postligation. Running time on a motor-driven treadmill was used to represent exercise capacity.
RESULTS: The histologic evaluation and microangiogram showed that the implanted BMCs induce angiogenesis. Blood flow to the adductor muscle on the treated side in the bone marrow cell implantation (BMI) group was significantly restored to 77.3 +/- 19.3% of that of the normally perfused limb in comparison to that in control groups (P < 0.05). AVDO(2) in the BMI group significantly decreased when compared with AVDO(2) in control groups. Rats in the BMI group ran approximately 1.5 times longer than rats in control groups at 2 and 4 weeks postligation (P < 0.01).
CONCLUSIONS: Implantation of autologous BMCs induced angiogenesis and improved deteriorated exercise capacity in our rat ischemic hindlimb model. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11266284     DOI: 10.1006/jsre.2000.6080

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  16 in total

1.  Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease.

Authors:  Abdul Jalil Rufaihah; Ngan F Huang; Sina Jamé; Jerry C Lee; Ha N Nguyen; Blake Byers; Abhijit De; Janet Okogbaa; Mark Rollins; Renee Reijo-Pera; Sanjiv S Gambhir; John P Cooke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 2.  Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells.

Authors:  Nicholas J Leeper; Arwen L Hunter; John P Cooke
Journal:  Circulation       Date:  2010-08-03       Impact factor: 29.690

3.  Cell therapy for cardiovascular diseases.

Authors:  Kaoru Tateno; Tohru Minamino; Junji Moriya; Akemi Katada; Masataka Yokoyama; Kentaro Miura; Issei Komuro
Journal:  Ann Vasc Dis       Date:  2008-10-24

4.  A functional murine model of hindlimb demand ischemia.

Authors:  Michael A Peck; Robert S Crawford; Christopher J Abularrage; Virendra I Patel; Mark F Conrad; Jin Hyung Yoo; Michael T Watkins; Hassan Albadawi
Journal:  Ann Vasc Surg       Date:  2010-04-02       Impact factor: 1.466

Review 5.  Tissue Engineering of the Microvasculature.

Authors:  Joe Tien
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

6.  Co-culture of mesenchymal stem cells with umbilical vein endothelial cells under hypoxic condition.

Authors:  Bo Zhang; Shuhua Yang; Yukun Zhang; Zhibo Sun; Weihua Xu; Shunan Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

7.  Multipotent adult progenitor cells sustain function of ischemic limbs in mice.

Authors:  Xabier L Aranguren; Jonathan D McCue; Benoit Hendrickx; Xiao-Hong Zhu; Fei Du; Eleanor Chen; Beatriz Pelacho; Ivan Peñuelas; Gloria Abizanda; Maialen Uriz; Sarah A Frommer; Jeffrey J Ross; Betsy A Schroeder; Meredith S Seaborn; Joshua R Adney; Julianna Hagenbrock; Nathan H Harris; Yi Zhang; Xiaoliang Zhang; Molly H Nelson-Holte; Yuehua Jiang; An D Billiau; Wei Chen; Felipe Prósper; Catherine M Verfaillie; Aernout Luttun
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

8.  Involvement of bone marrow-derived endothelial progenitor cells in glomerular capillary repair in habu snake venom-induced glomerulonephritis.

Authors:  Yoko Abe-Yoshio; Katsushige Abe; Masanobu Miyazaki; Akira Furusu; Tomoya Nishino; Takashi Harada; Takehiko Koji; Shigeru Kohno
Journal:  Virchows Arch       Date:  2008-06-13       Impact factor: 4.064

9.  Therapeutic assessment of mesenchymal stem cells delivered within a PEGylated fibrin gel following an ischemic injury.

Authors:  Laura M Ricles; Pei-Ling Hsieh; Nicholas Dana; Viktoriya Rybalko; Chelsea Kraynak; Roger P Farrar; Laura J Suggs
Journal:  Biomaterials       Date:  2016-06-07       Impact factor: 12.479

10.  Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesis.

Authors:  Bruno Amato; Rita Compagna; Gianni Antonio Della Corte; Giovanni Martino; Tommaso Bianco; Guido Coretti; Roberto Rossi; Antonio Braucci; Giovanni Aprea; Pio Zeppa; Alessandro Puzziello; Claudio Terranova
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.